undefined undefined
NaN.000
NaN.00%
来源:华兴资本 “华兴资本医疗与生命科技行业周报”定期发布,专注从资本角度解读一周数据,并提供最新行业观察。 医疗与生命科技是华兴资本多年来关注并深耕的领域,目...
今天 09:30
Results from the Phase 3 SOLARIS trial of TEV-‘749 for schizophrenia treatment. SteadyTeq technology ensures controlled olanzapine release. Clinically meaningful improvements in PANSS scores observed across dosing groups.
05-09 01:49
Teva Pharmaceuticals, a U.S.-based unit of the generic drugmaker Teva (NYSE:TEVA) and French drug developer MedinCell (OTC:MDCLF), announced Wednesday that TEV-‘749, a subcutaneously delivered schizop...
05-08 19:40
Collaboration enables accelerated materials discovery to optimize product development/ Key HighlightsAnsys and Schrödinger are collaborating to develop an integrated computational materials engineering (ICME)
05-07 21:13
Synopsys seals a $2.1 billion deal with Clearlake Capital Group, L.P. and Francisco Partners, elevating its focus on core chip design by divesting its Software Integrity Group business to a new standalone entity. Led by existing management, the move aims to revolutionize software development, enhancing innovation while mitigating business risks.
05-07 01:53
Synopsys (NASDAQ:SNPS) is in advanced discussions to sell its $2B software integrity unit to a private equity consortium, led by Clearlake Capital and Francisco Partners. The two PE shops prevailed ov...
05-03 02:02
Analysts have been eager to weigh in on the Technology sector with new ratings ...
05-02 16:11
ANSYS shares are trading lower after the company reported worse-than-expected Q...
05-02 05:23
Ansys (NASDAQ:ANSS) reported quarterly earnings of $1.39 per share which missed the analyst consensus estimate of $1.91 by 27.23 percent. The company reported quarterly sales of $466.60 million which missed the analyst
05-02 04:33
Ansys multiphysics platforms support TSMC's latest silicon technologies, enabling advanced semiconductor vendors to create faster, lower power designs / Key Highlights Ansys RedHawk-SC™ and ...
04-30 21:00